Key facts
- Notable investors include Ollin Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for NeuroNova
- ·The full record, as it builds
Funding rounds
No funding rounds for NeuroNova are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NeuroNova
Manufacturer of non-invasive neuromodulation technology and lifestyle and wellness products designed to help individuals elevate their cognitive performance, support natural dopamine regulation, and optimize the nervous system. The company offers precise spinal vibration technology to gently activate sensory pathways, enabling clients to achieve mental clarity, emotional resilience, and a reset nervous system without the use of medication.
- Sector
- Healthcare
- HQ
- Provo, UT, United States
- Founded
- 2022
- Website
- neuronovaco.com/
- Ownership
- Privately Held (backing)
NeuroNova doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NeuroNova shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NeuroNova in its N-PORT filings yet. We sweep new filings monthly.